Sentiment read — Options markets delivered a split signal this week. Japanese financial names dominated call-side extremes, with SMFG and MUFG both logging 52-week highs in bullish positioning. Simultaneously, bearish protection spiked across US financials, energy, and healthcare names — suggesting investors rotated defensively even as select pockets attracted aggressive call buying.
The most persistent signal of the week. SMFG triggered high-severity options pulses on three consecutive days — May 19, 20, 21, and 22. Its put/call ratio hit a 52-week record high of 0.61. That figure is still below 1.0, but against a 20-day baseline of just 0.06, the +4.2 standard-deviation move is extreme. Hedging demand built steadily into the week's close.
The opposite story. MUFG crashed to its lowest PCR in 52 weeks. Traders shifted sharply bullish following a three-month earnings beat. Call buying dominated the options tape. The divergence between SMFG and MUFG — two Japanese megabanks — signals split conviction rather than a unified sector view.
Takeda Pharmaceutical recorded a 52-week high PCR on three separate days this week. The ratio reached 2.36, against a 20-day mean of just 0.32. Put buying was extreme and persistent. Short sellers also retreated — making the bearish options positioning the more notable divergence.
KKR hit a 52-week high PCR twice in two days. The stock had fallen 7.4% over the prior month. Options traders loaded up on downside protection. The reading approached 4 standard deviations above the 20-day average on both occurrences — a rare clustering of extreme bearish positioning.
Constellation Energy saw its PCR hit a 52-week record as shares fell 12.6% over the week. The ratio sat 4 standard deviations above the 20-day mean. It was the steepest absolute put-loading signal among US large-caps this week.
PepsiCo flipped to aggressive call buying. Its PCR dropped to 0.55 — the lowest level since at least April 2025. The 4.2 standard-deviation move below the 20-day average signals unusually strong bullish conviction. The shift arrived without a major price catalyst, making it a positioning-led move.
Zscaler rallied 17.3% over the week. Yet its PCR spiked sharply. Options traders bought puts into the rally — a classic hedging pattern following fast-moving gains. The 4-sigma read indicates hedging pressure was well beyond normal levels for the stock.
IQVIA recorded its highest put/call ratio since at least April 2025. At 1.99 — more than double the 20-day average — it reflected heavy downside hedging. This was among the most elevated absolute PCR readings in the US large-cap space this week.
The VanEck Pharmaceutical ETF's PCR hit a multi-year extreme. A reading of 2.37 — the highest in nearly five years — signals extreme bullish options sentiment on the sector ETF. The timing coincides with broader defensive rotation out of healthcare policy risk.
Japanese bank ADRs generated the week's most striking options divergence. SMFG attracted persistent put hedging to a 52-week extreme. MUFG saw the opposite — a 52-week low PCR on post-earnings bullish positioning. MFG (Mizuho) also spiked to 4.3 standard deviations above its mean, with its PCR at 0.68 as the stock fell 3.5%. Traders are not reading Japanese banks as a uniform story.
Multiple US financials registered elevated PCRs simultaneously. COF spiked to 1.35 (4σ), with traders buying protection ahead of July earnings. AIG hit 1.42–1.47 (4σ). Regional banks MTB and RF both logged 52-week or multi-year PCR highs. BFH reached 2.44, a 4-sigma move, as its stock fell 6.5% on the month. The cluster suggests broad sector-level hedging rather than idiosyncratic stock bets.
TAK drove sustained bearish positioning all week. IQV hit a 13-month PCR high. Yet PPH — the pharmaceutical ETF — logged a near-five-year bullish extreme. The contradiction likely reflects stock-specific stress in contract research and Japanese pharma, while the broader drug pipeline view remains constructive.
ZS led with a 4-sigma PCR spike despite a 17% weekly gain. QGEN (Qiagen) hit 4.3 standard deviations above its mean, as shares fell 18% over the month following analyst downgrades. EEFT (Euronet) moved in the opposite direction — logging a 52-week low PCR of 0.48–0.54 across three sessions, signalling persistent call-side accumulation throughout the week.
SPTL, the SPDR Long-Term Treasury ETF, saw its PCR crash to 0.22 — a 4-sigma move below its 20-day mean of 0.46 and a 52-week low. Aggressive call buying in a long-duration rate product signals a meaningful shift in interest rate sentiment among options traders.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
